Gilead Analysis Shows Remdesivir Reduced Coronavirus Death Risk

Gilead Sciences Inc said on Friday an analysis showed its antiviral remdesivir helped reduce the risk of death in severely ill COVID-19 patients, but cautioned that rigorous clinical trials were...